MedTrace Logo

Markerless Image Guidance Using Intrafraction Kolovoltage X-ray Imaging for Lung Cancer Radiotherapy

NCT04310891 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2026-01-29

No results posted yet for this study

Summary

In radiotherapy, tumour tracking allows us to ensure the radiation beam is accurately targeting the tumour while it moves in a complex and unpredictable way. Most tumour tracking techniques require the implantation of fiducial markers around the tumour. Markerless Tumour Tracking negates the need for implanted markers, enabling accurate and optimal cancer radiotherapy in a non-invasive way.

Conditions

  • Lung Cancer
  • Markerless Image Guidance
  • Intrafraction Kolovoltage X-ray Imaging

Interventions

RADIATION

Markerless Tumour Tracking

Intrafraction Kolovoltage X-ray Imaging using Fiducials

Sponsors & Collaborators

  • University of Sydney

    collaborator OTHER

  • Royal North Shore Hospital

    lead OTHER

Principal Investigators

  • Dasantha Jayamanne, MD · Royal North Shore Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-04
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Australia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04310891 on ClinicalTrials.gov